Dear fellow researchers:
I am working on osteosarcoma cells (U2OS) and am looking for ways to block TGF-Beta signaling pathway (towards Oct-4). Has anyone tried anything related to this experiment? Any recommended product that may work with a great probability? Any suggestions for an experimental design?
Sincerely,
Udesh.
Hi @ Udesh Dhawan, maybe you can see the answer in article below:
Article TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
Hi Bayu Winata It seems SD-208 is a potent inhibitor of TGF-B R1. Thanks for the help!
Inhibiting the whole branch of SMAD2/SMAD3 pathway, I would use SB43152 (usually at concentrations between 1-10uM depending on the cell type)
Thanks Tobias A Beyer , I will be working with U2OS.
I am wondering if the TGFB signaling target that I want to study is happening through non-canonical pathway, then will this work or not.
SB targets the kinase domain of the receptor, so that means it might not work on the non-canonical pathway.
You mention OCT4 as target, (I assume POU5F1?). In hESCs at least, the enhancer is bound by SMAD2/4 complexes.
Do you add the TGFb to your medium or is it autocrine signaling? If you add it, you can ommit the ligand in the medium (and remove the serum if added)
I checked the Smad2/3 expression and both genes are modulated, which means that signaling is happening through Canonical pathway. I'll give SB43152 a try. Thanks mate.
- Badges
- Science topic
- Similar topics
- Medicine
- Oncology
- Cancer Research
- Cancer Biology